The annual global pharmaceutical industry event, FCE Pharma 2024 (Brazil International Pharmaceutical Ingredients Exhibition), was successfully held from June 4th to 6th at the S\u00e3o Paulo Northern Exhibition Center in Brazil. As an innovative representative of China’s high-end \u00a0new\u00a0medical materials field, Shanghai JSD\u00a0New\u00a0Medical Material\u00a0Co., Ltd\u00a0(hereinafter referred to as “JSD”) launched its innovative co-injection cap product for blow-fill-seal (BFS) technology infusion bottles at the exhibition. With its superior technology and performance, it sets a new benchmark for the safety and efficiency of large-volume infusion packaging globally, becoming a major focus of attention during the exhibition.<\/p>\n
BFS technology, as an advanced aseptic manufacturing process, is increasingly widely used in the field of infusion products, placing extremely high demands on the sealing performance, compatibility, and ease of opening of packaging caps. JSD’s co-injection cap, showcased at the event, is tailor-made to address these core needs. This product employs an advanced multi-layer co-injection molding process, fusing polymer materials with different properties under precise control, cleverly achieving a perfect combination of “high mechanical strength in the outer layer and excellent sealing and compatibility in the inner layer”.<\/p>\n
At the exhibition, JSD\u00a0New\u00a0Medical Material\u00a0Co., through product demonstrations, cross-sectional structural analysis, and multimedia presentations, explained in detail the core advantages of its co-injection cap to pharmaceutical company representatives, technical experts, and buyers from around the world.<\/p>\n
\u2022 Excellent seal integrity: Effectively prevents oxygen and moisture penetration, ensuring the sterility and stability of the medicine throughout its shelf life and significantly reducing the risk of leakage.<\/p>\n
\u2022 Excellent drug compatibility: The inner contact material strictly adheres to pharmaceutical-grade standards, with extremely low dissolution and exudation, fully ensuring the safety of sensitive drugs.<\/p>\n
\u2022 The user-friendly opening design balances ease of opening with clear identification of broken rings, facilitating operation by medical staff while ensuring medication safety and preventing reuse.<\/p>\n
\u2022 Strong production line adaptability: The product design is precisely matched with mainstream BFS high-speed filling production lines, demonstrating excellent stability and production efficiency.<\/p>\n
JSD’s booth attracted a large number of attendees, particularly professionals from major South American and international pharmaceutical companies, who showed strong interest in collaborating on this innovative solution. Many clients engaged in in-depth technical exchanges on-site, highly praising the samples and reaching several preliminary cooperation and testing agreements.<\/p>\n
The Overseas Market Director of Shanghai JSD\u00a0New\u00a0Medical Material Co., Ltd stated at the exhibition: \u201cWe are very pleased to launch our strategic product\u2014BFS infusion bottle co-injection caps\u2014to the global market on the international stage of FCE Pharma. The South American market is a key area for the application of BFS technology, and we deeply understand the needs of local customers for high-quality packaging accessories. The enthusiastic response at this exhibition fully demonstrates the correctness of our innovative direction. JSD\u00a0is committed to becoming the most trusted packaging solution partner for global pharmaceutical companies, and we will continue to contribute our professional strength to improving global drug safety and manufacturing standards, driven by technological innovation.\u201d<\/p>\n
The success of this trip to Brazil marks a significant step forward for Shanghai JSD\u00a0New\u00a0Medical Material Co., Ltd\u00a0on its internationalization strategy. The company will continue to focus on the research and development of new medical materials, serving the global pharmaceutical and healthcare industry with a more diverse and advanced product line, and bringing the innovative achievements of “Made in China” to the world.<\/p>\n